Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for

Core Viewpoint - The market anticipates Elevance Health (ELV) will report a year-over-year decline in earnings despite higher revenues for the quarter ending September 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Elevance Health is expected to report quarterly earnings of $4.97 per share, reflecting a year-over-year decrease of 40.6%, while revenues are projected to reach $49.5 billion, an increase of 10.7% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.57% higher in the last 30 days, indicating a collective reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +3.36% for Elevance Health, suggesting analysts have recently become more optimistic about the company's earnings prospects [12]. Historical Performance - In the last reported quarter, Elevance Health was expected to post earnings of $9.16 per share but delivered $8.84, resulting in a surprise of -3.49%. Over the last four quarters, the company has beaten consensus EPS estimates twice [13][14]. Investment Considerations - Despite a positive Earnings ESP, Elevance Health carries a Zacks Rank of 4, making it challenging to predict an earnings beat conclusively [12]. Investors should consider other factors beyond earnings results when evaluating the stock [15][17].